ArticleAbdominal radiology (New York)2026
An explainable clinical-radiomics machine learning model for preoperative prediction of WHO/ISUP nuclear grade in clear cell renal cell carcinoma.
Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundAccurate preoperative assessment of the WHO/ISUP nuclear grade of clear cell renal cell carcinoma (ccRCC) is critical for guiding individualized surgical strategies and prognostic evaluation. However, current grading still depends on postoperative pathology. This study aimed to develop and validate a noninvasive, machine learning-based model integrating clinical and radiomic features for predicting WHO/ISUP pathological grade in ccRCC.
methodsA total of 415 patients with pathologically confirmed ccRCC were retrospectively enrolled, including 320 for model development and 95 for external validation. Clinical variables significantly associated with tumor grade in univariate analysis were further analyzed using multivariate logistic regression and machine learning algorithms. Radiomic features were extracted from preoperative CT images and screened using three strategies: least absolute shrinkage and selection operator (LASSO), principal component analysis (PCA), and maximum relevance minimum redundancy (mRMR). Twelve algorithms-including Random Forest (RF), XGBoost, LightGBM, and Support Vector Machine (SVM)-were trained and validated. Model performance was evaluated by area under the curve (AUC), accuracy, sensitivity, specificity, and negative predictive value (NPV). Model interpretability was assessed using SHAP (SHapley Additive Explanations) analysis.
resultsSix independent predictors of WHO/ISUP grade were identified: body mass index (BMI), maximum tumor diameter, perirenal infiltration, serum albumin (SA), osmolality (OSM), and neuron-specific enolase (NSE). Among clinical-only models, RF achieved the best performance (AUC = 0.852, 0.734, and 0889 in training, test, and external validation cohorts, respectively). Incorporating radiomic features further improved prediction accuracy. In the combined LASSO-RF model, the external validation cohort achieved an AUC of 0.912 (95% CI: 0.854-0.970), accuracy of 0.853, sensitivity of 0917, and specificity of 0.831. SHAP analysis revealed that OSM, SA, and NSE were the most influential features, while radiomic texture features such as log-sigma-1-mm-3D first-order maximum also contributed significantly.
conclusionThe LASSO-RF model integrating clinical and radiomic features demonstrated excellent accuracy and generalizability for predicting WHO/ISUP grade in ccRCC. This noninvasive approach enables individualized preoperative grading and risk stratification, providing valuable support for nephron-sparing surgical decision-making and precision oncology in renal cancer management.
Indexed as
Identifiers
42033642What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.